Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The genus Enterovirus combines a portion of small (+)ssRNA-containing viruses and is divided into 10 species of true enteroviruses and three species of rhinoviruses. These viruses are causative agents of the widest spectrum of severe and deadly epidemic diseases of higher vertebrates, including humans. Their ubiquitous distribution and high pathogenici- ty motivate active search to counteract enterovirus infections. There are no sufficiently effective drugs targeted against enteroviral diseases, thus treatment is reduced to supportive and symptomatic measures. This makes it extremely urgent to develop drugs that directly affect enteroviruses and hinder their development and spread in infected organisms. In this review, we cover the classification of enteroviruses, mention the most common enterovirus infections and their clinical man- ifestations, and consider the current state of development of anti-enteroviral drugs. One of the most promising targets for such antiviral drugs is the viral Internal Ribosome Entry Site (IRES). The classification of these elements of the viral mRNA translation system is also examined.

作者简介

O. Nikonov

Institute of Protein Research

Email: katya_nik@vega.protres.ru
俄罗斯联邦, Pushchino, Moscow Region, 142290

E. Chernykh

Institute of Protein Research

Email: katya_nik@vega.protres.ru
俄罗斯联邦, Pushchino, Moscow Region, 142290

M. Garber

Institute of Protein Research

Email: katya_nik@vega.protres.ru
俄罗斯联邦, Pushchino, Moscow Region, 142290

E. Nikonova

Institute of Protein Research

编辑信件的主要联系方式.
Email: katya_nik@vega.protres.ru
俄罗斯联邦, Pushchino, Moscow Region, 142290


版权所有 © Pleiades Publishing, Ltd., 2017
##common.cookie##